Key Points
- In current PCI practice, anticoagulation with either bivalirudin or unfractionated heparin in patients with ACS share comparable efficacy and safety.
- Nonetheless, their individual performance in patients on dialysis remains unclear.
- This observational PCI study reported in-hospital clinical outcome in patients on dialysis undergoing PCI according to drug regimen: bivalirudin versus heparin.
- Similar clinical outcome was observed with both drug regimens.
from #AlexandrosSfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2hfOjbe
via IFTTT
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου